HSPA1A and cancer: Clinical trials portrayed in Table 2 assess HSP70-based approaches like vaccines, inhibitors and antibodies across various cancers, investigating its impact on immune responses, tumour regression and diagnostic potential for circulating tumour cells (CTCs).